Results 261 to 270 of about 2,074,577 (363)
An Update of Immunohistochemistry in Hepatocellular Carcinoma. [PDF]
Li B, Huang L, Huang J, Li J.
europepmc +1 more source
Epidemiology and surveillance for hepatocellular carcinoma: New trends.
A. Singal, P. Lampertico, P. Nahon
semanticscholar +1 more source
This review summarizes the design principles and key features of programmable hydrogels that respond to multiple stimuli. It then delves into the cutting‐edge mechanisms of self‐executing systems, highlighting their role as the cornerstone of next‐generation programmable hydrogels (NGPHs).
Guangli Xiang +8 more
wiley +1 more source
NLR Risk Score for Predicting Patient Prognosis in Hepatocellular Carcinoma and Identification of Oncogenic Role of NLRP5 in Hepatocellular Carcinoma. [PDF]
Tang M +14 more
europepmc +1 more source
A valence‐engineered CeOX nanozyme, with its Ce3+/Ce4+ ratio precisely controlled within the range of 0.27 to 0.93 through Au deposition, performs a self‐cascade oxidase‐superoxide dismutase‐peroxidase reaction, enabling continuous reactive oxygen species scavenging while minimizing oxygen generation.
Ge Wang +10 more
wiley +1 more source
Distribution of basement membrane components in human hepatocellular carcinoma [PDF]
Maria Francesca Donato +3 more
openalex +1 more source
Natural killer cells, central to anti‐tumor defense, undergo unexpected reprogramming within the tumor microenvironment. Instead of producing IFN‐γ and TNF‐α, they elevate amphiregulin, a tumor‐promoting factor. This shift is linked to glucocorticoid receptor activity and prostaglandin signaling.
Qin Wei +8 more
wiley +1 more source
When the unexpected strikes: hepatocellular carcinoma in a teen with ataxia-telangiectasia. [PDF]
Alesaeidi S +5 more
europepmc +1 more source
Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma [PDF]
Lijie Ma +14 more
openalex +1 more source
The Bimetallic Nanozyme Amplifier (PEG@AuCZ@CC) to maximize hydrogen peroxide production and reprogram tumor metabolism from glycolysis to oxidative phosphorylation. This shift enhances ferroptotic/cuproptotic signaling cascades and creates a glucose‐enriched but lactate‐depleted tumor microenvironment (TME), effectively overcoming immune tolerance in ...
Jianzhang Luo +9 more
wiley +1 more source

